Geode Capital Management LLC Has $201.82 Million Stake in Chemed Co. (NYSE:CHE)

Geode Capital Management LLC raised its stake in Chemed Co. (NYSE:CHE) by 4.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 335,443 shares of the company’s stock after purchasing an additional 15,791 shares during the quarter. Geode Capital Management LLC owned 2.23% of Chemed worth $201,820,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. Thrivent Financial for Lutherans raised its position in Chemed by 300.3% in the 2nd quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock valued at $63,249,000 after buying an additional 87,449 shares during the last quarter. International Assets Investment Management LLC purchased a new stake in shares of Chemed in the third quarter valued at about $437,150,000. Impax Asset Management Group plc lifted its position in shares of Chemed by 19.5% during the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock valued at $172,510,000 after purchasing an additional 51,974 shares in the last quarter. FMR LLC lifted its position in shares of Chemed by 23.8% during the third quarter. FMR LLC now owns 238,616 shares of the company’s stock valued at $143,401,000 after purchasing an additional 45,917 shares in the last quarter. Finally, Epoch Investment Partners Inc. boosted its holdings in Chemed by 22.1% during the second quarter. Epoch Investment Partners Inc. now owns 223,134 shares of the company’s stock worth $121,068,000 after purchasing an additional 40,358 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Down 1.1 %

Shares of NYSE CHE opened at $547.00 on Monday. The business has a 50-day simple moving average of $570.70 and a two-hundred day simple moving average of $564.96. The company has a market cap of $8.23 billion, a P/E ratio of 27.64, a P/E/G ratio of 2.32 and a beta of 0.46. Chemed Co. has a 52 week low of $523.33 and a 52 week high of $654.62.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. During the same period in the previous year, the company earned $5.32 EPS. Chemed’s quarterly revenue was up 7.4% on a year-over-year basis. Equities research analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date was Monday, November 18th. Chemed’s payout ratio is currently 10.11%.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares in the company, valued at $62,117,555.35. This represents a 1.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the transaction, the executive vice president now owns 18,287 shares in the company, valued at approximately $10,526,362.94. This represents a 3.85 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,132 shares of company stock valued at $3,003,502. 3.32% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Royal Bank of Canada decreased their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.